Senseonics Holdings Inc SENS:NYSE American

Last Price$2.84AMEX Previous Close - Last Trade as of 8:00PM ET 1/14/22
AMEX 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$2.85 (4)
Ask (Size)$2.90 (5)
Day Low / HighN/A - N/A
Volume6.0 M
 

View Electronic Components IndustryPeer Comparison as of 01/14/2022

 

Senseonics Holdings Inc ( NYSE MKT LLC )

Price: $2.84
Change: +0.06 (2.16%)
Volume: 6.0 M
8:00PM ET 1/14/2022
 
 

CTS Corp ( NYSE )

Price: $35.84
Change: +0.36 (1.01%)
Volume: 91.6 K
7:00PM ET 1/14/2022
 
 

Benchmark Electronics Inc ( NYSE )

Price: $26.99
Change: +0.58 (2.20%)
Volume: 121.0 K
7:00PM ET 1/14/2022
 
 

TTM Technologies Inc ( NASDAQ )

Price: $15.29
Change: +0.26 (1.73%)
Volume: 1.0 M
4:00PM ET 1/14/2022
 
 

NeoPhotonics Corp ( NYSE )

Price: $15.11
Change: -0.03 (0.20%)
Volume: 988.4 K
7:00PM ET 1/14/2022
 

Read more news Recent News

Sector Update: Health Care Stocks Mixed Ahead of Wednesday's Open
8:51AM ET 1/05/2022 MT Newswires

Health care stocks were mixed ahead of the opening bell on Wednesday. The Health Care SPDR (XLV) gained 0.2% and the iShares Biotechnology ETF (IBB)...

Top Premarket Gainers
8:20AM ET 1/05/2022 MT Newswires

Mainz Biomed (MYNZ) shares soared 83% after the company acquired exclusive rights to a portfolio of mRNA biomarkers for potential use in cancer detection...

Senseonics Says FDA Decision on Approval of Eversense Glucose Monitor Expected in Coming Weeks -- Shares Rise After-Hours
5:23PM ET 1/04/2022 MT Newswires

Senseonics Holdings (SENS) said late Tuesday it expects the US Food and Drug Administration's decision around the approval of its continuous glucose...

Senseonics Says Diabetes Remote Monitoring App for Android Users Gets Europe's CE Mark
9:34AM ET 12/21/2021 MT Newswires

Senseonics (SENS), a maker of continuous glucose monitoring systems for diabetes, said Monday it received Europe's CE mark for its Eversense remote...

View all Commentary and Analysis

Senseonics: Shares Primed For 180-Day Approval
4:10PM ET 12/22/2021 Seeking Alpha

Senseonics Holdings (SENS) Investor Presentation
1:17PM ET 11/23/2021 Seeking Alpha

Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q3 2021 Results - Earnings Call Transcript
7:10PM ET 11/09/2021 Seeking Alpha

Senseonics Holdings: Will Not Fail For Lack Of Intent
7:42AM ET 10/06/2021 Seeking Alpha

Company Profile

Business DescriptionSenseonics Holdings, Inc. engages in the design, development, and commercialization of implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a gluscose monitoring device which includes sensor, smart transmitter, and mobile application. The company was founded on June 26, 2014 and is headquartered in Germantown, MD. View company web site for more details
Address20451 Seneca Meadows Parkway
Germantown, Maryland 20876-7005
Phone+1.301.515.7260
Number of Employees192
Recent SEC Filing01/05/20224
President, Chief Executive Officer & DirectorTimothy T. Goodnow
Chief Operating OfficerMukul Jain
Secretary, Chief Financial & Accounting OfficerNick B Tressler
Director & Chief Medical OfficerFrancine R. Kaufman

Company Highlights

Price Open$2.74
Previous Close$2.78
52 Week Range$1.48 - 5.56
Market Capitalization$1.3 B
Shares Outstanding446.0 M
SectorElectronic Technology
IndustryElectronic Components
Next Earnings Announcement03/03/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.56
Beta vs. S&P 500N/A
Revenue$18.9 M
Net Profit Margin-3,604.91%
Return on Equity215.58%

Analyst Ratings as of 10/28/2021

Buy
3
Overweight
0
Hold
2
Underweight
0
Sell
2
Consensus RecommendationConsensus Icon
Powered by Factset